1233749-00-2

Usage

Uses

Unfortunately, the provided materials do not mention any specific applications or uses for (S,E)-3-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexanol. However, given its complex structure and multiple functional groups, it may have potential applications in various industries such as pharmaceuticals, materials science, or chemical research. Further investigation and research would be required to determine its specific uses and benefits.

Upstream product

• 170081-45-5 3(S)-<(tert-butyldimethylsilyl)oxy>-20(S)-(iodomethyl)-9,10-secopregna-5(E),7(E),10(19)-triene 
• 140710-90-3 25-hydroxy-5E-[6,19,19'-H3]vitamin D3-3β-tert-butyldimethylsilyl ether 
• 50-14-6 Calciferol 
• 104973-33-3 6(S),19-(N,N'-phthalhydrazido)-3,25-dihydroxy-9,10-secocholesta-5⁽¹⁰⁾,7(E)-diene 
• 104973-32-2 6(S),19-(N,N'-phthalhydrazido)-3β-acetoxy-25-hydroxy-9,10-secocholesta-5(10),7(E),22(Z)-triene 
• 87417-00-3 6(S),19-(N,N'-phthalhydrazido)-3β-acetoxy-9,10-secoergosta-5(10),7(E),22(E)-triene 
• 87417-16-1 C₂₉H₄₀OPSi⁽¹⁺⁾*C₂₄H₂₀B^(1-) 
• 104875-13-0 Acetic acid (2S,14S)-14-[(1R,3aS,7aR)-1-((Z)-(R)-1,5-dimethyl-5-triethylsilanyloxy-hex-2-enyl)-7a-methyl-octahydro-inden-(4E)-ylidenemethyl]-7,12-dioxo-1,2,3,4,5,7,12,14-octahydro-phthalazino[2,3-b]phthalazin-2-yl ester 
• 104849-51-6 Toluene-4-sulfonic acid (S)-2-{(1R,3aS,7aR)-4-[1-(2,2-dioxo-6-triethylsilanyloxy-2,3,4,5,6,7-hexahydro-1H-2λ⁶-benzo[c]thiophen-1-yl)-meth-(E)-ylidene]-7a-methyl-octahydro-inden-1-yl}-propyl ester 
• 104973-29-7 6(S),19-(N,N'-phthalhydrazido)-3β-acetoxy-20(S)-formyl-9,10-secopregna-5(10),7(E)-diene 
• 87680-61-3 Triethyl-{(S)-3-[(1R,3aS,7aR)-7a-methyl-1-((E)-(1R,4R)-1,4,5-trimethyl-hex-2-enyl)-octahydro-inden-(4E)-ylidenemethyl]-2,2-dioxo-2,3,4,5,6,7-hexahydro-1H-2λ⁶-benzo[c]thiophen-5-yloxy}-silane 
• 87680-62-4 (S)-2-{(1R,3aS,7aR)-4-[1-((S)-2,2-Dioxo-6-triethylsilanyloxy-2,3,4,5,6,7-hexahydro-1H-2λ⁶-benzo[c]thiophen-1-yl)-meth-(E)-ylidene]-7a-methyl-octahydro-inden-1-yl}-propionaldehyde 
• 87407-50-9 (S)-2-{(1R,7aR)-4-[1-((S)-2,2-Dioxo-6-triethylsilanyloxy-2,3,4,5,6,7-hexahydro-1H-2λ⁶-benzo[c]thiophen-1-yl)-meth-(E)-ylidene]-7a-methyl-octahydro-inden-1-yl}-propan-1-ol 
• 87407-52-1 3β-<(triethylsilyl)oxy>-20(S)-(hydroxymethyl)-9,10-secopregna-5(E),7(E),10(19)-triene 

Downstream Products

• 87417-20-7 3,5-Dinitro-benzoic acid (S)-3-[2-[(1R,3aS,7aR)-1-((R)-5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-(4E)-ylidene]-eth-(E)-ylidene]-4-methylene-cyclohexyl ester 
• 19356-17-3 calcidiol 

Relevant academic research and scientific papers

Preparation method of 25-hydroxyvitamin D3, 1alpha, 25-dihydroxyvitamin D3 and isotope internal standard compound thereof

The invention discloses a preparation method of 25-hydroxyvitamin D3 and 1alpha, 25-dihydroxyvitamin D3 and an isotope internal standard compound thereof. The preparation method comprises the following steps: a compound III is subjected to SO2 conjugate protection, O3 oxidation, NaBH4 reduction, iodination ring opening, conjugate addition with acrylate, and reaction with a methyl Grignard reagentor isotope labeled methyl Grignard reagent, a silicon protecting group is removed under the action of TBAF, and a product is obtained through ultraviolet irradiation configuration inversion under thecatalysis of 9-acetyl anthracene. The method is good in reaction selectivity, high in total yield, simple and convenient to operate and short in isotope introduction step, and the isotope utilizationrate is greatly increased.